Clinical trial
A Randomized Controlled Non-Inferiority Study for Shortening Tuberculosis Treatment With Sitafloxacin-Containing Regimens
NCT05454345 is registered in ClinicalTrials.gov with First Affiliated Hospital of Zhejiang University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Non-Inferiority Study for Shortening Tuberculosis Treatment With Sitafloxacin-Containing Regimens
- Lead sponsor
- First Affiliated Hospital of Zhejiang University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 1, 2022
- Completion date
- June 30, 2026
- Enrollment
- 620 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.